1. Home
  2. DENN vs LYEL Comparison

DENN vs LYEL Comparison

Compare DENN & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DENN
  • LYEL
  • Stock Information
  • Founded
  • DENN 1953
  • LYEL 2018
  • Country
  • DENN United States
  • LYEL United States
  • Employees
  • DENN N/A
  • LYEL N/A
  • Industry
  • DENN Restaurants
  • LYEL Biotechnology: Pharmaceutical Preparations
  • Sector
  • DENN Consumer Discretionary
  • LYEL Health Care
  • Exchange
  • DENN Nasdaq
  • LYEL Nasdaq
  • Market Cap
  • DENN 317.7M
  • LYEL 369.4M
  • IPO Year
  • DENN 1989
  • LYEL 2021
  • Fundamental
  • Price
  • DENN $6.14
  • LYEL $17.13
  • Analyst Decision
  • DENN Buy
  • LYEL Buy
  • Analyst Count
  • DENN 6
  • LYEL 2
  • Target Price
  • DENN $5.45
  • LYEL $15.00
  • AVG Volume (30 Days)
  • DENN 3.5M
  • LYEL 25.2K
  • Earning Date
  • DENN 11-03-2025
  • LYEL 11-12-2025
  • Dividend Yield
  • DENN N/A
  • LYEL N/A
  • EPS Growth
  • DENN N/A
  • LYEL N/A
  • EPS
  • DENN 0.20
  • LYEL N/A
  • Revenue
  • DENN $457,212,000.00
  • LYEL $41,000.00
  • Revenue This Year
  • DENN $7.62
  • LYEL N/A
  • Revenue Next Year
  • DENN $1.92
  • LYEL N/A
  • P/E Ratio
  • DENN $31.31
  • LYEL N/A
  • Revenue Growth
  • DENN 0.93
  • LYEL N/A
  • 52 Week Low
  • DENN $2.85
  • LYEL $7.65
  • 52 Week High
  • DENN $7.66
  • LYEL $23.20
  • Technical
  • Relative Strength Index (RSI)
  • DENN 66.48
  • LYEL 50.42
  • Support Level
  • DENN $6.10
  • LYEL $16.08
  • Resistance Level
  • DENN $6.18
  • LYEL $18.60
  • Average True Range (ATR)
  • DENN 0.13
  • LYEL 1.26
  • MACD
  • DENN 0.12
  • LYEL -0.09
  • Stochastic Oscillator
  • DENN 97.86
  • LYEL 36.75

About DENN Denny's Corporation

Denny's Corp is America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees. Geographically operates in USA states as well as globally like Canada, Mexico, Guatemala, Indonesia, United Kingdom, New Zealand and others. Maximum revenue is from USA and Canada.

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Share on Social Networks: